Author information from the last article
Medisinsk avdeling
Bærum sykehus
og
K.G. Jebsen-senter for B-cellekreft
Oslo universitetssykehus
Forfatterbidrag: datainnsamling, analyse og tolking av data, litteratursøk, utarbeiding og godkjenning av manuskriptet.
Anders Tveita er ph.d., lege i spesialisering og forsker.
Articles by Anders Tveita
COVID-19 patients treated with convalescent plasma
- Lise Sofie Haug Nissen-Meyer,
- Magnhild Eide Macpherson,
- Linda Gail Skeie,
- Marte Hvalryg,
- Abid Hussain Llohn,
- Tine Torsvik Steinsvåg,
- Mona Høysæter Fenstad,
- Anders Tveita,
- Einar K. Kristoffersen,
- Tatjana Sundic,
- Fridtjof Lund-Johansen,
- John Torgils Vaage,
- Øystein Flesland,
- Anne Ma Dyrhol-Riise,
- Jan Cato Holter,
- Tor Audun Hervig,
- Børre Fevang
03.08.2023:
COVID-19 convalescent plasma (NORPLASMA) (1) first became available to Norwegian patients in the spring of 2020. The Norwegian Directorate of Health recommended use of the product in patients who were at risk of developing a severe/life-threatening course of COVID-19, where the attending doctor...
Three waves of COVID-19 in a Norwegian local hospital
- Marius Myrstad,
- Peter Selmer Rønningen,
- Anders Tveita,
- Else Johanne Rønning,
- Per Erik Ernø,
- Elizabeth Lyster Andersen,
- Marte Meyer Walle-Hansen,
- Andrew Campbell Robertson,
- Monica Thallinger,
- Jan Svendsen,
- Sigurd Haakonsen,
- Arnljot Tveit,
- Håkon Ihle-Hansen
13.01.2022:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic with more than 255 million confirmed infections and more than 5 million deaths (1). As of 17 November 2021, there were more than 232 000 confirmed infections, and 995 deaths had been caused by COVID-19 in...
Pulmonary embolism in cases of COVID-19
- Anders Tveita,
- Siv Hestenes,
- Eirik Robsahm Sporastøyl,
- Stian Aleksander Pettersen,
- Bente Lund Neple,
- Marius Myrstad,
- Arnljot Tveit,
- Hege Frøen,
- Jan Svendsen,
- Else Johanne Rønning
06.05.2020:
Here we describe pulmonary embolism in three patients at different stages of COVID-19. The development of pulmonary embolism can be easy to overlook if respiratory failure and hypoxemia are attributed to SARS-CoV-2 pneumonia. The clinical picture associated with COVID-19 is complicated by severe...
COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital
- Håkon Ihle-Hansen,
- Trygve Berge,
- Anders Tveita,
- Else Johanne Rønning,
- Per Erik Ernø,
- Elizabeth Lyster Andersen,
- Christian Hjorth Wang,
- Arnljot Tveit,
- Marius Myrstad
10.04.2020:
COVID-19 (coronavirus disease 2019) is caused by infection with the virus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which belongs to the coronavirus family. The first case among humans very probably arose at the beginning of December 2019 at a food market in Wuhan in Hubei...